Facing a large open market with its new product, Medistim is very well positioned to accelerate its growth in the U.S. market. Medistim has since 2007 been represented in the U.S. market. In December 2010 Medistim received the trust of the American health authorities, the Food and Drug Administration (FDA) for its new product, VeriQC and is now in an exciting phase of market introduction, not just a new product, but a new paradigm for quality assurance: By combining the established transit time flow measurement (TTFM) technology to perform epiaortic ultrasound scanning (EUS), will further reduce the risk for health-threatening and potentially fatal complications.

Medistim develops and sells medical equipment for use in cardiovascular surgery and other surgical areas. Read press release "Medistim styrker sin kommersielle organisasjon i USA"